001     138286
005     20240321220416.0
024 7 _ |a 10.1084/jem.20150478
|2 doi
024 7 _ |a pmid:26458770
|2 pmid
024 7 _ |a pmc:PMC4612086
|2 pmc
024 7 _ |a 0022-1007
|2 ISSN
024 7 _ |a 1540-9358
|2 ISSN
024 7 _ |a 1540-9538
|2 ISSN
024 7 _ |a altmetric:4619585
|2 altmetric
037 _ _ |a DZNE-2020-04608
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Varvel, Nicholas H
|0 P:(DE-2719)2810540
|b 0
|e First author
|u dzne
245 _ _ |a Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease.
260 _ _ |a New York, NY
|c 2015
|b Rockefeller Univ. Press
264 _ 1 |3 online
|2 Crossref
|b Rockefeller University Press
|c 2015-10-12
264 _ 1 |3 print
|2 Crossref
|b Rockefeller University Press
|c 2015-10-19
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1593002562_30277
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Immune cells of myeloid lineage are encountered in the Alzheimer's disease (AD) brain, where they cluster around amyloid-β plaques. However, assigning functional roles to myeloid cell subtypes has been problematic, and the potential for peripheral myeloid cells to alleviate AD pathology remains unclear. Therefore, we asked whether replacement of brain-resident myeloid cells with peripheral monocytes alters amyloid deposition in two mouse models of cerebral β-amyloidosis (APP23 and APPPS1). Interestingly, early after repopulation, infiltrating monocytes neither clustered around plaques nor showed Trem2 expression. However, with increasing time in the brain, infiltrating monocytes became plaque associated and also Trem2 positive. Strikingly, however, monocyte repopulation for up to 6 mo did not modify amyloid load in either model, independent of the stage of pathology at the time of repopulation. Our results argue against a long-term role of peripheral monocytes that is sufficiently distinct from microglial function to modify cerebral β-amyloidosis. Therefore, myeloid replacement by itself is not likely to be effective as a therapeutic approach for AD.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Amyloid beta-Peptides
|2 NLM Chemicals
650 _ 7 |a Membrane Glycoproteins
|2 NLM Chemicals
650 _ 7 |a Receptors, Immunologic
|2 NLM Chemicals
650 _ 7 |a Trem2 protein, mouse
|2 NLM Chemicals
650 _ 2 |a Alzheimer Disease: metabolism
|2 MeSH
650 _ 2 |a Alzheimer Disease: pathology
|2 MeSH
650 _ 2 |a Alzheimer Disease: therapy
|2 MeSH
650 _ 2 |a Amyloid beta-Peptides: metabolism
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Brain: metabolism
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Membrane Glycoproteins: analysis
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mice, Inbred C57BL
|2 MeSH
650 _ 2 |a Monocytes: physiology
|2 MeSH
650 _ 2 |a Myeloid Cells: physiology
|2 MeSH
650 _ 2 |a Receptors, Immunologic: analysis
|2 MeSH
700 1 _ |a Grathwohl, Stefan A
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Degenhardt, Karoline
|0 P:(DE-2719)2810939
|b 2
|u dzne
700 1 _ |a Resch, Claudia
|0 P:(DE-2719)9000263
|b 3
|u dzne
700 1 _ |a Bosch, Andrea
|0 P:(DE-2719)2380523
|b 4
|u dzne
700 1 _ |a Jucker, Mathias
|0 P:(DE-2719)2000010
|b 5
|u dzne
700 1 _ |a Neher, Jonas J
|0 P:(DE-2719)2811021
|b 6
|e Last author
|u dzne
773 1 8 |a 10.1084/jem.20150478
|b : Rockefeller University Press, 2015-10-12
|n 11
|p 1803-1809
|3 journal-article
|2 Crossref
|t Journal of Experimental Medicine
|v 212
|y 2015
|x 1540-9538
773 _ _ |a 10.1084/jem.20150478
|g Vol. 212, no. 11, p. 1803 - 1809
|0 PERI:(DE-600)1477240-1
|n 11
|q 212:11<1803 - 1809
|p 1803-1809
|t Journal of experimental medicine
|v 212
|y 2015
|x 1540-9538
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612086
909 C O |o oai:pub.dzne.de:138286
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810540
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810939
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000263
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2380523
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2000010
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2811021
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EXP MED : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b J EXP MED : 2017
920 1 _ |0 I:(DE-2719)1210001
|k AG Jucker
|l Cell Biology of Neurologic Diseases
|x 0
920 1 _ |0 I:(DE-2719)1210012
|k AG Neher
|l Experimental neuroimmunology
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210001
980 _ _ |a I:(DE-2719)1210012
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1038/nn2014
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nn2014
999 C 5 |a 10.1523/JNEUROSCI.22-02-00515.2002
|9 -- missing cx lookup --
|2 Crossref
|o 10.1523/JNEUROSCI.22-02-00515.2002
999 C 5 |a 10.1126/science.1171242
|9 -- missing cx lookup --
|2 Crossref
|o 10.1126/science.1171242
999 C 5 |a 10.1038/nature10907
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nature10907
999 C 5 |a 10.1038/nm1555
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nm1555
999 C 5 |a 10.1016/j.neuron.2014.02.040
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuron.2014.02.040
999 C 5 |a 10.1038/nn.2432
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nn.2432
999 C 5 |a 10.1056/NEJMoa1211851
|9 -- missing cx lookup --
|2 Crossref
|o 10.1056/NEJMoa1211851
999 C 5 |a 10.1111/acel.12149
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/acel.12149
999 C 5 |a 10.1038/ni.3102
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.3102
999 C 5 |a 10.1038/nm1177
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nm1177
999 C 5 |a 10.1016/j.immuni.2015.03.011
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.immuni.2015.03.011
999 C 5 |a 10.1126/scitranslmed.3002369
|9 -- missing cx lookup --
|2 Crossref
|o 10.1126/scitranslmed.3002369
999 C 5 |a 10.1084/jem.20142322
|9 -- missing cx lookup --
|2 Crossref
|o 10.1084/jem.20142322
999 C 5 |a 10.1371/journal.pone.0060921
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0060921
999 C 5 |a 10.1038/ng.2802
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.2802
999 C 5 |a 10.1016/j.cell.2014.11.018
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.cell.2014.11.018
999 C 5 |a 10.1523/JNEUROSCI.0329-10.2010
|9 -- missing cx lookup --
|2 Crossref
|o 10.1523/JNEUROSCI.0329-10.2010
999 C 5 |a 10.1523/JNEUROSCI.6209-10.2011
|9 -- missing cx lookup --
|2 Crossref
|o 10.1523/JNEUROSCI.6209-10.2011
999 C 5 |a 10.1038/nn.2923
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nn.2923
999 C 5 |a 10.1084/jem.20150479
|9 -- missing cx lookup --
|2 Crossref
|o 10.1084/jem.20150479
999 C 5 |a 10.1038/sj.embor.7400784
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.embor.7400784
999 C 5 |a 10.1016/j.neuron.2006.01.022
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuron.2006.01.022
999 C 5 |a 10.1007/s00401-009-0556-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00401-009-0556-6
999 C 5 |a 10.1073/pnas.94.24.13287
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.94.24.13287
999 C 5 |a 10.1038/nm1781
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nm1781
999 C 5 |a 10.1186/1750-1326-9-20
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1750-1326-9-20
999 C 5 |a 10.1073/pnas.1210150109
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.1210150109
999 C 5 |a 10.1016/j.cell.2015.01.049
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.cell.2015.01.049
999 C 5 |a 10.1101/cshperspect.a006346
|9 -- missing cx lookup --
|2 Crossref
|o 10.1101/cshperspect.a006346


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21